Home > Financial Ratios > ORCHID PHARMA

ORCHID PHARMA
EV/EBIT

    Back to All Ratios
COMMUNITY POLL
for ORCHID PHARMA
Please provide your vote to see the results

ORCHID PHARMA Last 5 Year EV/EBIT History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/EBIT(x) 47.5621.21-60.59-243.82-6.83

What is the latest EV/EBIT ratio of ORCHID PHARMA ?

The latest EV/EBIT ratio of ORCHID PHARMA is 47.56 based on Mar2024 Consolidated results.
Year EV/EBIT
Mar202447.56
Mar202321.21
Mar2022-60.59
Mar2021-243.82
Mar2020-6.83

How is EV/EBIT of ORCHID PHARMA Trending?

Years EV/EBIT % Change
Mar2024 47.56
124.23
Mar2023 21.21
Positive
Mar2022 -60.59
Negative
Mar2021 -243.82
Negative
Mar2020 -6.83 -

Other Financial Ratios of ORCHID PHARMA


Compare EV/EBIT ratio of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹4,159.7 Cr -2.7% 5.6% -26.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹440,314.0 Cr -0.4% 5.7% 20.2% Stock Analytics
DIVIS LABORATORIES ₹162,809.0 Cr 1.7% 6.2% 52.9% Stock Analytics
CIPLA ₹124,627.0 Cr -0.7% 7% 8.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹111,127.0 Cr -1.6% 1.5% 21.1% Stock Analytics
DR REDDYS LABORATORIES ₹97,839.9 Cr -2.3% 2.5% -6% Stock Analytics


ORCHID PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

-2.7%

5.6%

-26.9%

SENSEX

2%

4.1%

9.6%


You may also like the below Video Courses